首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   828篇
  免费   87篇
  国内免费   21篇
耳鼻咽喉   1篇
儿科学   24篇
妇产科学   5篇
基础医学   51篇
口腔科学   54篇
临床医学   93篇
内科学   290篇
皮肤病学   7篇
神经病学   11篇
特种医学   13篇
外科学   102篇
综合类   117篇
预防医学   57篇
眼科学   15篇
药学   78篇
中国医学   16篇
肿瘤学   2篇
  2023年   17篇
  2022年   33篇
  2021年   38篇
  2020年   53篇
  2019年   49篇
  2018年   49篇
  2017年   33篇
  2016年   25篇
  2015年   23篇
  2014年   55篇
  2013年   52篇
  2012年   51篇
  2011年   41篇
  2010年   29篇
  2009年   37篇
  2008年   26篇
  2007年   31篇
  2006年   29篇
  2005年   23篇
  2004年   30篇
  2003年   29篇
  2002年   29篇
  2001年   17篇
  2000年   19篇
  1999年   15篇
  1998年   9篇
  1997年   11篇
  1996年   13篇
  1995年   14篇
  1994年   6篇
  1993年   4篇
  1992年   6篇
  1991年   5篇
  1990年   4篇
  1989年   2篇
  1988年   7篇
  1987年   4篇
  1986年   5篇
  1985年   5篇
  1984年   1篇
  1982年   1篇
  1981年   2篇
  1978年   1篇
  1977年   1篇
  1969年   1篇
  1967年   1篇
排序方式: 共有936条查询结果,搜索用时 937 毫秒
1.
2.
实验室驯化的中华按蚊,通过人胎盘膜,吸取含马来丝虫微丝蚴的新鲜兔血而获感染。在温度为28℃,相对湿度为75-85%的实验条件下,观察了中华按蚊感染马来丝虫主存活率的变化。结果表明,感染微丝蚴密度最高组蚊的存活率比其它各组明显下降。  相似文献   
3.
We report herein the case of a 42-year-old man in whom dyspnea on exertion was found to be caused by isolated tricuspid stenosis. Two-dimensional echocardiogram showed thickening of the tricuspid valve with a markedly enlarged right atrium. A color-flow Doppler examination-revealed severe tricuspid stenosis without regurgitation and a Doppler-derived tricuspid diastolic pressure gradient of 23 mmHg. At the time of surgery, the patient was noted to have a stenotic tricuspid valve with thickened leaflets, fused commissures, and almost normal chorda tendineae. The valve leaflets were teased apart to the scattered specimen, and tricuspid valve replacement was successfully performed. Microscopic examination of the specimen demonstrated infective endocarditis. Isolated acquired tricuspid stenosis is extremely rare and, to our knowledge, this is the first case of infective endocarditis being involved as the primary cause.  相似文献   
4.
目的:使输液疗法中药物不良反应降到最低限度,使患者获得安全、有效的治疗,同时,也是对有限药物资源的维护。方法:对用四类抗感染药物出现不良反应91例患者行减慢输液速度、平卧、松解领扣、按合谷穴、心理护理、保暖、进饮食等处置。结果:91例药物不良反应,有89例顺利完成输液治疗,2例无效,更换药物。结论:有责任感,加强观察护理及时发现患者反应前驱症状,迅速采取有效措施,会取得满意效果。  相似文献   
5.
We describe a case of successful combined repair of the aortic and mitral valves for an indication of active infective endocarditis involving both valves. Mitral valve repair was achieved by vegetation debridement, fixation of the anterior mitral commissure, resection and suturing of the posterior mitral leaflet, and posterior annuloplasty with autologous pericardium. Aortic valve repair was achieved by vegetectomy and commissural plication. Postoperative clinical course was without signs of recurrent infection, and echocardiogram demonstrated mitral valve competence with trivial aortic regurgitation. We concluded that simultaneous valve repair is a viable option in the context of active endocarditis.  相似文献   
6.
Infective endocarditis is an infrequent but serious complication in heart transplant recipients. We report successful treatment for this serious complication.  相似文献   
7.
人工心脏瓣膜感染性心内膜炎临床分析   总被引:1,自引:0,他引:1  
目的 探讨人工心脏瓣膜感染性心内膜炎 (PVE)的临床特征 ,提高PVE的诊治水平。方法 通过分析 2 6例PVE的临床表现 ,分析其治疗和预后情况。结果 PVE临床不少见 ,发热是最常见的临床表现 ( 92 .3 % ) ,其次是贫血 ( 88.5% ) ,栓塞 ( 2 6.9% )。血培养和超声心动图是诊断PVE的重要手段 ,阳性率分别为 46.2 %和 73 .1%。早期PVE较晚期PVE预后差、死亡率高 ,分别为 66.7%、3 3 .3 %。主张早期、大剂量、长疗程的抗生素治疗 ,早期手术治疗可改善预后。本组病人总死亡率 3 4 .7% ,死亡原因 :心力衰竭 ( 77.8% )、栓塞 ( 2 2 .2 % )。结论 PVE预后差、死亡率高 ,应早期预防、早期诊断、早期治疗  相似文献   
8.
改进简单催化模型中感染力函数的判别准则   总被引:2,自引:0,他引:2  
李文潮  徐勇勇 《医学争鸣》1992,13(4):271-274
  相似文献   
9.
Current epidemiological trends of infective endocarditis (IE) in Greece were investigated via a prospective cohort study of all cases of IE that fulfilled the Duke criteria during 2000-2004 in 14 tertiary and six general hospitals in the metropolitan area of Athens. Demographics, clinical data and outcome were compared for nosocomial IE (NIE) and community-acquired IE (CIE). NIE accounted for 42 (21.5%) and CIE for 153 (78.5%) of 195 cases. Intravenous drug use was associated exclusively with CIE, while co-morbidities (cardiovascular disease, diabetes mellitus, chronic renal failure requiring haemodialysis and malignancies) were more frequent in the NIE group (p <0.05). Prosthetic valve endocarditis (PVE) predominated in the NIE group (p 0.006), and >50% of NIE cases had a history of vascular intervention. Coagulase-negative staphylococci and enterococci were more frequent in cases of NIE than in cases of CIE (26.2% vs. 5.2%, p <0.01, and 30.9% vs. 16.3%, p 0.05, respectively). Enterococci accounted for 19.5% of total IE cases and were the leading cause of NIE. Staphylococcus aureus IE was hospital-acquired in only 11.9% of cases. In-hospital mortality was higher for NIE than for CIE (39.5% vs. 18.6%, p 0.02). Cardiac failure (New York Heart Association grade III-IV; OR 13.3, 95% CI 4.9-36.1, p <0.001) and prosthetic valve endocarditis (OR 3.7, 95% CI 1.3-10.6, p 0.01) were the most important predictors of mortality.  相似文献   
10.
Introduction and importanceThe infective endocarditis incidence data for patients undergoing aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium (Ozaki procedure) are rare, and the optimal surgical treatment strategy remains unclear.Case presentationThis is the first case report of surgical treatment of infective endocarditis of aortic valve with cryopreserved homograft in an athlete with previously performed Ozaki procedure.Clinical discussionThe choice of homograft was dictated by the young age of the patient; professional activity as an athlete; refusal of anticoagulants and the need for wide excision of compromised tissues to mitigate potential risk of spread of infection as well as its recurrence.ConclusionThe use of the aortic homograft allowed us to radically remove the infected tissues and achieve hemodynamic characteristics similar to the native valve. This is probably the first case report of use of homograft to treat aortic valve endocarditis following Ozaki procedure.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号